Dr. Stephen Scionti is the most experienced HIFU physician in the U.S. using the alternative prostate cancer treatment for customized treatment.
Prostate Cancer Screening, Clinical Outcomes for Cancer Drugs Granted Accelerated Approval, Lupus Review, and more Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the May 7, 2024, issue....
For prostate cancer patients undergoing radiation therapy, maintaining quality of life may be just as important as treating the cancer. SpaceOAR Hydrogel for prostate cancer Dr. Marcio Fagundes,Radiation Oncologist, describes his experience using SpaceOAR Hydrogel including clinical considerations, ...
2010 The Prostate Cancer Treatment Bazaar Archives of Internal Medicine Invited Commentary March 8, 2010 See More About Oncology Prostate Cancer Radiation Oncology Surgery Surgical Oncology Urology Urologic Cancer Trending Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveil...
Department of Surgery, Cancer Research Building, Washington University in St Louis, 660 Euclid Ave., St Louis, MO, 63110, USA Thanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, Audrey Wilson, Kiran Mahajan & Nupam P. Mahajan Department of Urology, Cancer Research Building, Washington University in...
Prostate cancer (PCa) is the most common malignancy in men. Despite aggressive therapy involving surgery and hormonal treatments, the recurrence and emergence of metastatic castration-resistant prostate cancer (CRPCa) remain a major challenge. Dysregulation of the transforming growth factor-β (TGF-β...
Surgery and/or radiation therapies can be employed to treat prostate cancer and further to prevent progression of the disease. However, in some cases systemic therapy based on inhibiting the androgen receptor (AR) is employed. The androgen receptor is a steroid receptor transcription factor which ...
2010 The Prostate Cancer Treatment Bazaar Archives of Internal Medicine Invited Commentary March 8, 2010 See More About Oncology Prostate Cancer Radiation Oncology Surgery Surgical Oncology Urology Urologic Cancer Trending Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveil...
Therefore, the availability of the modality and the surgeon’s level of comfort would dictate the type of surgery offered to patients. Hence, AEEP and RASP have both mitigated the risks associated with OSP while conserving equivalent functional outcomes; however, AEEP offers the advantage of a ...
Figure 1. Effect of heteronemin (A) on (B) cellular viability of human prostate cancer LNcap and PC3 cells in a dose-dependent manner for 24 h and (C) cellular growth of human prostate cancer LNcap cells in a time-dependent manner for 24, 48 and 72 h, respectively. Results are shown...